STAT+: Key data on a new class of cardio drugs are coming

GSK’s shingles vaccine, new financial investment in women’s health, and more biotech news from The Readout Adobe Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We are thinking of Dolly Parton, who made a lasting impact not only in music and culture, but also in science. During the Covid-19 pandemic, she donated $1 million to Vanderbilt University Medical Center to help speed the development of Moderna’s vaccine.pharma Key data on a new class of cardio drugs are coming Several large pharma companies are betting that targeting a particle called lipoprotein(a) will be the next big advance in cardiovascular medicine. We’ll soon find out how well the approach works. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe National Biotech Reporter Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.